No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs201450559 |
chr3:191092888-191092889 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs200531070 |
chr3:191092896-191092897 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs201472875 |
chr3:191092948-191092949 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs146653620 |
chr3:191093001-191093002 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs150340096 |
chr3:191093006-191093007 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs138153104 |
chr3:191093019-191093020 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs527802654 |
chr3:191093024-191093025 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs115771997 |
chr3:191093028-191093029 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs199687225 |
chr3:191093029-191093030 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs375874806 |
chr3:191093045-191093046 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs2028572 |
chr3:191093053-191093054 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
12 |
rs566185695 |
chr3:191093068-191093069 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs567369598 |
chr3:191093071-191093072 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs2028573 |
chr3:191093080-191093081 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs371781270 |
chr3:191093082-191093083 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs142679286 |
chr3:191093100-191093101 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs368899630 |
chr3:191093102-191093103 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs144454149 |
chr3:191093126-191093127 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs570376411 |
chr3:191093128-191093129 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs140411108 |
chr3:191093147-191093148 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs148784496 |
chr3:191093152-191093153 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs2028574 |
chr3:191093175-191093176 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
23 |
rs373978431 |
chr3:191093189-191093190 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs534593003 |
chr3:191093190-191093191 |
Weak transcription Genic enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs199527848 |
chr3:191093223-191093224 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs574188668 |
chr3:191093229-191093230 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs550615746 |
chr3:191093264-191093265 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs536886962 |
chr3:191093271-191093272 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs75123867 |
chr3:191093285-191093286 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs201801914 |
chr3:191093288-191093289 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs4677728 |
chr3:191093310-191093311 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
32 |
rs144268061 |
chr3:191093314-191093315 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs572378113 |
chr3:191093351-191093352 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs541413193 |
chr3:191093373-191093374 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs376689351 |
chr3:191093375-191093376 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs370769473 |
chr3:191093382-191093383 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs4677729 |
chr3:191093384-191093385 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
38 |
rs530179056 |
chr3:191093388-191093389 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs375958338 |
chr3:191093396-191093397 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs370227079 |
chr3:191093397-191093398 |
Weak transcription Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs373683606 |
chr3:191093410-191093411 |
Weak transcription Strong transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs77846288 |
chr3:191093419-191093420 |
Weak transcription Strong transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|